ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.026,13
0,87%
Dow Jones
43.221,47
-0,17%
Euro vs US Dollar
1,03981
-0,01%
Bitcoin
95.429,83
-3,90%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. IN8bio Inc (INAB) Börsenkurse

IN8bio Inc

IN8bio Inc (INAB)

NASDAQ
0,246
0,0114
( 4,86% )
Aktualisiert: 15:51:50
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,246
Gebot
0,2408
Fragen
0,26
Volumen
67.159
0,2351 Tagesbereich 0,2587
0,217 52-Wochen-Bereich 1,93
Marktkapitalisierung
17,831M
Handelsende
0,2346
Handelsbeginn
0,244
Letzte Trade
50
@
0.2534
Letzter Handelszeitpunkt
15:51:35
Finanzvolumen
US$ 16.486
VWAP
0,245476
Durchschnittliches Volumen (3 Mio.)
1.305.635
Ausgegebene Aktien
72.483.253
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,56
Gewinn pro Aktie (EPS)
-0,41
Erlöse
-
Nettogewinn
-30,01M

Über IN8bio Inc

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.in8bio.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was US$0,23. Over the last year, IN8bio shares have traded in a share price range of US$ 0,217 to US$ 1,93.

IN8bio currently has 72.483.253 shares in issue. The market capitalisation of IN8bio is US$17,00 million. IN8bio has a price to earnings ratio (PE ratio) of -0.56.

INAB Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

10 Dezember 2024
Edgar (US Regulatory)

IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting

INB-100 continues to demonstrate durable complete remissions (CR) with no relapses observed in any acute myeloid leukemia (AML) patients including those with high-risk disease after a median...

10 Dezember 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.019-7.169811320750.2650.2650.23037901280.24280256CS
4-0.055-18.27242524920.3010.410.23038143420.31279323CS
12-0.0273-9.989023051590.27330.55660.21713056350.37720043CS
26-0.664-72.9670329670.910.920.2177287570.40170698CS
52-1.004-80.321.251.930.2175443530.65827103CS
156-5.904-966.156.660.2176892812.05199541CS
260-9.754-97.541010.3190.2176118792.1083835CS

INAB - Frequently Asked Questions (FAQ)

What is the current IN8bio share price?
The current share price of IN8bio is US$ 0,246
How many IN8bio shares are in issue?
IN8bio has 72.483.253 shares in issue
What is the market cap of IN8bio?
The market capitalisation of IN8bio is USD 17M
What is the 1 year trading range for IN8bio share price?
IN8bio has traded in the range of US$ 0,217 to US$ 1,93 during the past year
What is the PE ratio of IN8bio?
The price to earnings ratio of IN8bio is -0,56
What is the reporting currency for IN8bio?
IN8bio reports financial results in USD
What is the latest annual profit for IN8bio?
The latest annual profit of IN8bio is USD -30,01M
What is the registered address of IN8bio?
The registered address for IN8bio is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the IN8bio website address?
The website address for IN8bio is www.in8bio.com
Which industry sector does IN8bio operate in?
IN8bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGIHMillennium Group International Holdings Ltd
US$ 6,5901
(330,73%)
36,72M
SPRCSciSparc Ltd
US$ 0,5715
(158,36%)
147,97M
COEPCoeptis Therapeutics Holdings Inc
US$ 0,3259
(129,51%)
102,89M
ZCARZoomcar Holdings Inc
US$ 3,00
(109,79%)
37,21M
ADDColor Star Technology Company Ltd
US$ 3,68
(70,37%)
16,76M
BAOSBaosheng Media Group Holdings Ltd
US$ 4,61
(-35,07%)
614,17k
NEUPNeuphoria Therapeutics Inc
US$ 4,65
(-29,86%)
199,6k
SVRESaverOne 2014 Ltd
US$ 1,07
(-29,14%)
584,28k
HOURHour Loop Inc
US$ 3,39
(-22,95%)
3,25M
DRCTDirect Digital Holdings Inc
US$ 2,9796
(-19,69%)
1,52M
SPRCSciSparc Ltd
US$ 0,5631
(154,57%)
148,15M
COEPCoeptis Therapeutics Holdings Inc
US$ 0,3323
(134,01%)
104,23M
SMXSMX Security Matters Public Company
US$ 0,33
(51,38%)
74,18M
ZCARZoomcar Holdings Inc
US$ 2,9801
(108,40%)
37,26M
MGIHMillennium Group International Holdings Ltd
US$ 6,5699
(329,41%)
37,11M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
INAB
IN8bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten